Taysha Gene Therapies, Inc. (TSHA) Total Assets by Year
Taysha Gene Therapies, Inc. closed fiscal year 2025 with $343.3M in total assets, $96.4M in total liabilities and $246.9M in shareholder equity. This represents an increase of 114.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Taysha Gene Therapies, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
TSHA Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K |
|---|---|---|---|---|---|---|
| Total Assets | $343.3M+114.1% | $160.4M-7.2% | $172.7M+36.8% | $126.3M-41.0% | $214.0M-17.4% | $258.9M |
| Total Liabilities | $96.4M+8.5% | $88.8M-9.2% | $97.8M-22.0% | $125.3M+5.7% | $118.6M+1464.5% | $7.6M |
| Total Equity | $246.9M+245.2% | $71.5M-4.6% | $74.9M+7796.4% | $949K-99.0% | $95.4M-62.0% | $251.3M |
TSHA Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $470.4M+41.1% | $300.4M+117.1% | $343.3M+114.1% | $316.6M+75.7% | $333.3M+66.3% | $138.4M-9.6% | $160.4M-7.2% | $180.2M-7.9% | $200.4M+145.8% | $153.0M+50.6% | $172.7M+36.8% | $195.8M+75.6% |
| Total Liabilities | $83.2M-1.7% | $88.4M+6.1% | $96.4M+8.5% | $97.6M+6.7% | $84.6M-7.6% | $83.3M-16.0% | $88.8M-9.2% | $91.4M-62.7% | $91.5M-22.9% | $99.2M-14.9% | $97.8M-22.0% | $244.9M+144.0% |
| Total Equity | $387.3M+55.7% | $211.9M+284.9% | $246.9M+245.2% | $219.0M+146.6% | $248.7M+128.5% | $55.1M+2.2% | $71.5M-4.6% | $88.8M+280.8% | $108.9M+393.3% | $53.8M+460.2% | $74.9M+7796.4% | -$49.1M-558.9% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Taysha Gene Therapies, Inc. financials
Frequently Asked Questions
What was Taysha Gene Therapies, Inc.'s total assets in fiscal year 2025?
Taysha Gene Therapies, Inc. closed fiscal year 2025 with $343.3M in total assets, $96.4M in total liabilities and $246.9M in shareholder equity.
How fast is Taysha Gene Therapies, Inc.'s total assets growing?
Taysha Gene Therapies, Inc. (TSHA) total assets rose by 114.1% year over year, from $160.4M to $343.3M in fiscal year 2025.
How has Taysha Gene Therapies, Inc.'s total assets changed over the years?
Across the 6 fiscal years this page covers, Taysha Gene Therapies, Inc. (TSHA) total assets went from $258.9M in fiscal year 2020 to $343.3M in fiscal year 2025.
What was Taysha Gene Therapies, Inc.'s total assets in the most recent quarter?
Taysha Gene Therapies, Inc. (TSHA) reported $470.4M in total assets in Q2 2026. This represents an increase of 41.1% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Taysha Gene Therapies, Inc. (TSHA) reported on that line in every period on record.